SCHEMBL6186843

SCHEMBL6186843

CCC(C)C(=O)Nc1ccc2[nH]c(C)c(C(=O)c3c(Cl)cccc3Cl)c2c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.40
HDAC8 Q9BY41 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA14 Q9ULX7 1/20 0.38
KDM4E B2RXH2 5/20 0.37
HSD17B10 Q99714 3/20 0.37
PRNP P04156 1/20 0.37
TSHR P16473 1/20 0.37
ALOX15 P16050 1/20 0.37
GAA P10253 1/20 0.37
DGAT1 O75907 1/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
KMT2A Q03164 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6188945 0.91 KMT2A (0.44) ALDH1A1HPGDHDAC8KDM4ETSHR
SCHEMBL6185825 0.89 TYK2 (0.45) ALDH1A1HPGDHDAC8KDM4EGAA
SCHEMBL6185686 0.81 DAPK3 (0.48) ALDH1A1HPGDKDM4EKMT2ARAB9A
SCHEMBL6189327 0.80 HPGD (0.46) ALDH1A1HPGDKDM4EALOX15GAA
SCHEMBL6185706 0.79 MAOB (0.42) ALDH1A1HPGDKDM4EPRNPMTNR1A
SCHEMBL6186285 0.78 MAOA (0.49) ALDH1A1KDM4EGAA
SCHEMBL6185134 0.77 MAOA (0.54) ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL6188852 0.75 RAB9A (0.55) ALDH1A1TSHRKMT2ARAB9A
SCHEMBL6190881 0.74 PARP1 (0.47) HPGDALOX15KMT2ARAB9A
SCHEMBL6185980 0.74 LMNA (0.41) ALDH1A1ALOX15GAAKMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554271-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2005-07-20 EP disclosed
WO-2004035571-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2004-04-29 WO disclosed